Search Results - "Pesci, Ilaria"
-
1
The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness
Published in Neurological sciences (01-03-2021)Get full text
Journal Article -
2
A longitudinal assessment of periodontal disease in Yorkshire terriers
Published in BMC veterinary research (21-06-2019)“…Periodontal disease is the most common oral disease of dogs and has been associated with systemic disease. The purpose of the present study was to determine…”
Get full text
Journal Article -
3
Sars-CoV2 infection in pregnant women with multiple sclerosis
Published in Multiple sclerosis (01-08-2023)“…Background: In the general population, maternal SARS-CoV-2 infection during pregnancy is associated with worse maternal outcomes; however, only one study so…”
Get full text
Journal Article -
4
Development of Yorkshire Terrier Dentition
Published in Veterinary sciences (21-06-2023)“…The development of dentition in dogs has been associated with several problems including tooth over-crowding, missing permanent dentition, and persistent…”
Get full text
Journal Article -
5
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
Published in Annals of neurology (01-04-2021)“…Objective This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019…”
Get full text
Journal Article -
6
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study
Published in Brain (London, England : 1878) (27-08-2022)“…Disability accrual in multiple sclerosis may occur as relapse-associated worsening or progression independent of relapse activity. The role of progression…”
Get full text
Journal Article -
7
“Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study
Published in Neurology (28-05-2019)“…BACKGROUNDThe exclusion of other diseases that can mimic multiple sclerosis (MS) is the cornerstone of current diagnostic criteria. However, data on the…”
Get full text
Journal Article -
8
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
Published in Multiple sclerosis (01-06-2022)“…Background: The MuSC-19 project is an Italian cohort study open to international partners that collects data on multiple sclerosis (MS) patients with COVID-19…”
Get full text
Journal Article -
9
Late-onset multiple sclerosis: disability trajectories in relapsing–remitting patients of the Italian MS Registry
Published in Journal of neurology (01-04-2024)“…Background Generally infrequent, multiple sclerosis (MS) with late onset (LOMS) is characterized by an onset over the age of 50 and a mainly progressive…”
Get full text
Journal Article -
10
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)
Published in Journal of neurology (01-10-2024)“…‘Active’ and ‘non-active’ secondary progressive MS (SPMS) have distinct pathophysiological mechanisms and clinical characteristics, but there is still no…”
Get full text
Journal Article -
11
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis
Published in JAMA neurology (01-06-2021)“…Availability of new disease-modifying therapies (DMTs) and changes of therapeutic paradigms have led to a general improvement of multiple sclerosis (MS)…”
Get more information
Journal Article -
12
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Published in Journal of neurology (01-08-2024)“…Objectives We investigated the occurrence and relative contribution of relapse-associated worsening (RAW) and progression independent of relapse activity…”
Get full text
Journal Article -
13
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis
Published in Annals of neurology (01-04-2022)“…Objective This study was undertaken to describe and compare disease course and prognosis of early (ie, disease onset before age 11 years) and late (ie, disease…”
Get full text
Journal Article -
14
Multiple Sclerosis Progression and Relapse Activity in Children
Published in JAMA neurology (01-01-2024)“…Although up to 20% of patients with multiple sclerosis (MS) experience onset before 18 years of age, it has been suggested that people with pediatric-onset MS…”
Get more information
Journal Article -
15
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Published in Journal of neurology (01-10-2024)Get full text
Journal Article -
16
Comparing the natural history of pediatric multiple sclerosis with onset before or after pubertal age (P1-5.005)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
17
Trajectories of disability and relapse-rate in naïve patients on oral drugs: results from the Italian Multiple Sclerosis Register (P17-4.003)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
18
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
Published in JAMA neurology (01-09-2022)“…Except for ocrelizumab, treatment options in primary progressive multiple sclerosis (PPMS) are lacking. To investigate the effectiveness of DMTs on the risk of…”
Get more information
Journal Article -
19
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients
Published in Journal of neurology (01-02-2024)“…Introduction During the COVID-19 pandemic, ocrelizumab (OCR) infusions for MS patients were often re-scheduled because of MS center's disruption and concerns…”
Get full text
Journal Article -
20
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study
Published in Journal of neurology (01-05-2018)“…In this independent, multicenter, retrospective study, we investigated the short-term persistence to treatment with first-line self-injectable or oral…”
Get full text
Journal Article